Published in Drug Week, March 26th, 2004
A recent survey by Greystone Associates concludes that intranasal administration is well-positioned to take advantage of these trends and to evolve into a significant role in the future of pharmaceutical development and commercialization.
"Drug developers and researchers are discovering that the accessibility and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.